Wuhan Easy Diagnosis Biomedicine: Announcement on the progress of the repurchase of company shares reaching 3%.
Wuhan Easy Diagnosis Biomedicine: Announcement regarding the progress of share buyback.
Wuhan Easy Diagnosis Biomedicine: 2023 Annual Equity Distribution Implementation Notice
Wuhan Easy Diagnosis Biomedicine: Announcement on the repurchase ratio of the company's shares reaching 2% and the progress of the repurchase
Wuhan Easy Diagnosis Biomedicine: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Wuhan Easy Diagnosis Biomedicine: 2023 Annual General Meeting of Shareholders Legal Opinions
Wuhan Easy Diagnosis Biomedicine: Investor Relations Activity Record Form
Wuhan Easy Diagnosis Biomedicine: Announcement on participating in the 2024 Online Group Reception Day for Investors of Listed Companies in Hubei Province and the 2023 Annual Results Briefing
Wuhan Easy Diagnosis Biomedicine: Announcement on the progress of share repurchases
Wuhan Easy Diagnosis Biomedicine: 2024 First Quarter Report
Wuhan Easy Diagnosis Biomedicine: Announcement of Board Resolutions
Wuhan Easy Diagnosis Biomedicine: Announcement of Supervisory Board Resolutions
Wuhan Easy Diagnosis Biomedicine: Guojin Securities Co., Ltd. inspection opinions on the annual storage and use of funds raised by Wuhan Mingde Biotechnology Co., Ltd. in 2023
Wuhan Easy Diagnosis Biomedicine: Verification Report on the Operating Income Deduction Statement
Wuhan Easy Diagnosis Biomedicine: Announcement on the renewal of the 2024 Audit Institution
Wuhan Easy Diagnosis Biomedicine: Annual Verification Report on the Use of Raised Funds
Wuhan Easy Diagnosis Biomedicine: Notice of Annual General Meeting of Shareholders
Wuhan Easy Diagnosis Biomedicine: Independent Director's Annual Debriefing Report (Xie Jincheng)
Wuhan Easy Diagnosis Biomedicine: Independent Director's Annual Debriefing Report (Shi Xianwang)
Wuhan Easy Diagnosis Biomedicine: 2023 ANNUAL REPORT
No Data